MPN/MDS Overlap Syndrome Anticipated by a Severe Bleeding Diathesis: Hypothesis of a Preexisting Platelet Disorder.
作者信息
Ranalli Paola, Baldoni Stefano, Bruno Daniela, Di Ianni Mauro
机构信息
Hematology Unit, Pescara Hospital, 65124 Pescara, Italy.
Department of Medicine and Aging Sciences, University of Chieti-Pescara, 66100 Chieti, Italy.
出版信息
Mediterr J Hematol Infect Dis. 2024 Sep 1;16(1):e2024067. doi: 10.4084/MJHID.2024.067. eCollection 2024.
Abstract
摘要
相似文献
1
MPN/MDS Overlap Syndrome Anticipated by a Severe Bleeding Diathesis: Hypothesis of a Preexisting Platelet Disorder.严重出血素质预示的骨髓增殖性肿瘤/骨髓增生异常综合征重叠综合征：血小板疾病预先存在的假说
Mediterr J Hematol Infect Dis. 2024 Sep 1;16(1):e2024067. doi: 10.4084/MJHID.2024.067. eCollection 2024.
2
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.SETBP1 突变发生在 9%的 MDS/MPN 和 4%的 MPN 病例中，与非典型 CML、单体 7、i(17)(q10) 等臂染色体、ASXL1 和 CBL 突变密切相关。
Leukemia. 2013 Sep;27(9):1852-60. doi: 10.1038/leu.2013.133. Epub 2013 Apr 30.
3
Genetic mutations associated with blood count abnormalities in myeloid neoplasms.与髓系肿瘤血细胞计数异常相关的基因突变。
Hematology. 2022 Dec;27(1):765-771. doi: 10.1080/16078454.2022.2094134.
4
mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome.作为骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征生物标志物的突变
Biomark Res. 2017 Dec 6;5:33. doi: 10.1186/s40364-017-0113-8. eCollection 2017.
5
Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.骨髓增生异常综合征/骨髓增生性肿瘤重叠综合征的基因组学。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):450-459. doi: 10.1182/hematology.2020000130.
6
Molecular genetics of MDS/MPN overlap syndromes.骨髓增生异常/骨髓增殖性肿瘤重叠综合征的分子遗传学。
Best Pract Res Clin Haematol. 2020 Sep;33(3):101195. doi: 10.1016/j.beha.2020.101195. Epub 2020 Jul 5.
7
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.孤立性 17q 等臂染色体的骨髓增生异常/骨髓增殖性肿瘤-不能分类代表一个独特的临床生物学亚组：来自骨髓病理学组的多机构合作研究。
Mod Pathol. 2022 Apr;35(4):470-479. doi: 10.1038/s41379-021-00961-0. Epub 2021 Nov 13.
8
Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.骨髓增生异常和骨髓增殖性肿瘤：重叠综合征的最新进展。
Leuk Lymphoma. 2018 Apr;59(4):803-812. doi: 10.1080/10428194.2017.1357179. Epub 2017 Aug 3.
9
Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.伴有环状铁粒幼细胞的难治性贫血（RARS）及伴有血小板增多的RARS（RARS-T）：2017年诊断、风险分层及管理的最新进展
Am J Hematol. 2017 Mar;92(3):297-310. doi: 10.1002/ajh.24637.
10
Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.骨髓增生异常综合征、费城染色体阴性的骨髓增殖性肿瘤以及重叠的骨髓增生异常综合征/骨髓增殖性肿瘤类别中细胞遗传学异常的分布情况。
Ann Hematol. 2009 Dec;88(12):1207-13. doi: 10.1007/s00277-009-0745-3. Epub 2009 May 5.
本文引用的文献
1
Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders.血小板功能、在血栓形成、炎症中的作用及其在慢性骨髓增殖性疾病中的后果。
Cells. 2021 Nov 5;10(11):3034. doi: 10.3390/cells10113034.
2
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.成人骨髓增生异常/骨髓增殖性肿瘤的分子特征和克隆结构。
Blood. 2020 Oct 15;136(16):1851-1862. doi: 10.1182/blood.2019004229.
3
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features.髓系恶性肿瘤中剪接因子基因的突变：意义及对临床特征的影响
Cancers (Basel). 2019 Nov 22;11(12):1844. doi: 10.3390/cancers11121844.
4
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
5
Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count.特发性血小板增多症患者血小板计数得到控制后血管性血友病因子的定性和定量变化。
J Thromb Haemost. 2015 Jul;13(7):1226-37. doi: 10.1111/jth.12967. Epub 2015 May 22.
6
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia.原发性血小板增多症和特发性血小板增多症中的血小板激活和抑制。
Blood. 2013 Mar 7;121(10):1701-11. doi: 10.1182/blood-2012-10-429134. Epub 2013 Jan 18.
7
Clinical and laboratory phenotype associated with the aspirin-like defect.与阿司匹林样缺陷相关的临床和实验室表型。
Br J Haematol. 2010 Feb;148(4):661-3; author reply 663-4. doi: 10.1111/j.1365-2141.2009.07950.x. Epub 2009 Oct 7.
8
Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families.与阿司匹林样缺陷相关的临床和实验室表型：对17个无关家族的研究
Br J Haematol. 2009 Feb;144(3):416-24. doi: 10.1111/j.1365-2141.2008.07468.x. Epub 2008 Nov 19.
9
Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.骨髓增殖性综合征中血小板血管性血友病因子异常
Am J Hematol. 1995 Aug;49(4):289-93. doi: 10.1002/ajh.2830490406.
10
Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.101例骨髓增殖性疾病的血栓出血并发症：与血小板数量和功能的关系
Eur J Cancer Clin Oncol. 1983 Nov;19(11):1593-9. doi: 10.1016/0277-5379(83)90091-3.
Zotero 插件